Home > Browse Issues > Vol.48 No.11

Research Advances in Cellular and Molecular Mechanisms of Liver Diseases Regulated by the Gut-Liver Axis and Related Biomarkers


HU Quandong1,2*, LI Meijing3, ZHOU Bin1, JIN Sihao1

(1Medical School of Shaoxing Vocational & Technical College, Shaoxing 312000, China; 2Basic Medical College of Nanchang University, Nanchang 330006, China; 3Hepatobiliary Surgery Department of Yantai Yuhuangding Hospital, Yantai 264000, China)
Abstract:

The gut-liver axis is a bidirectional signaling network formed between the gut and the liver via the portal vein and the biliary system, and its homeostatic balance is one of the key processes maintaining the body’s metabolic and immune homeostasis. Disruption of the gut-liver axis—manifesting as impaired intestinal barrier function, remodeling of gut microbiota composition and metabolism, and aberrant gut-liver signaling— constitutes a core pathological basis for the onset and progression of various liver diseases. This review systemati cally outlines the physiological regulatory foundations of the gut-liver axis, elaborates on the cellular and molecular mechanisms by which gut-liver axis disruption contributes to metabolic dysfunction-associated steatotic liver dis ease, alcohol-associated liver disease, acute liver injury, viral hepatitis, liver cirrhosis, and hepatocellular carci noma, summarizes the current status and clinical translation potential of disease-specific biomarkers derived from the gut-liver axis, and reviews advances in therapeutic strategies targeting the gut-liver axis, with a focus on cellular targets of gut-liver crosstalk regulation, thereby offering new theoretical insights and research directions for basic mechanistic studies and precision diagnosis and treatment of liver diseases.    


CSTR: 32200.14.cjcb.2026.11.0009